Inventia Healthcare Ltd

General

Total Cases8

Active Cases1

Patents7

CourtsD. Delaware D. New Jersey N.D. West Virginia

TypeOperating Company

Elite Ratings

--

inventiahealthcare.com

inventia-healthcare

inventia-healthcare

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/17/24	Vanda Pharmaceuticals Inc v. Inventia Healthcare Ltd 1:15-CV-00362 ( D. DE )	Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Platinum Equity for Inventia Healthcare Limited filed by Inventia Healthcare Limited. (Dorsney, Kenneth) (Entered: 09/17/2024)
09/17/24	Vanda Pharmaceuticals Inc v. Inventia Healthcare Ltd 1:15-CV-00362 ( D. DE )	Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Platinum Equity for Inventia Healthcare Limited filed by Inventia Healthcare Limited. (Dorsney, Kenneth) (Entered: 09/17/2024)
09/17/24	Vanda Pharmaceuticals Inc v. Inventia Healthcare Ltd 1:15-CV-00362 ( D. DE )	Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Platinum Equity for Inventia Healthcare Limited filed by Inventia Healthcare Limited. (Dorsney, Kenneth) (Entered: 09/17/2024)
09/17/24	Vanda Pharmaceuticals Inc v. Inventia Healthcare Ltd 1:15-CV-00362 ( D. DE )	Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Platinum Equity for Inventia Healthcare Limited filed by Inventia Healthcare Limited. (Dorsney, Kenneth) (Entered: 09/17/2024)
08/01/24	Catalyst Pharma Inc v. Inventia Healthcare Ltd 2:23-CV-22461 ( D. NJ )	CONSENT JUDGMENT that this District Court retains jurisdiction to enforce or supervise performance under this Consent Judgment and the Settlement Agreement; all claims, counterclaims, affirmative defenses and demands in this action are dismissed without prejudice and without costs, disbursements or attorneys' fees to any party; nothing herein shall preclude the U.S. Food & Drug Administration from granting final approval to Inventia's ANDA No. 218760. Signed by Judge Michael E. Farbiarz on 8/1/2024. (sm) (Entered: 08/01/2024) CONSENT JUDGMENT that this District Court retains jurisdiction to enforce or supervise performance under this Consent Judgment and the Settlement Agreement; all claims, counterclaims, affirmative defenses and demands in this action are dismissed without prejudice and without costs, disbursements or attorneys' fees to any party; nothing herein shall preclude the U.S. Food & Drug Administration from granting final approval to Inventia's ANDA No. 218760. Signed by Judge Michael E. Farbiarz on 8/1/2024. (sm) (Entered: 08/01/2024)
07/31/24	Catalyst Pharma Inc v. Inventia Healthcare Ltd 2:23-CV-22461 ( D. NJ )	Letter from Charles H. Chevalier to the Honorable Michael E. Farbiarz, U.S.D.J.. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 07/31/2024)
07/11/24	Vanda Pharmaceuticals Inc v. Inventia Healthcare Ltd 1:15-CV-00362 ( D. DE )	[SEALED] Joint STATUS REPORT - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 07/11/2024)
07/11/24	Vanda Pharmaceuticals Inc v. Inventia Healthcare Ltd 1:15-CV-00362 ( D. DE )	[SEALED] Joint STATUS REPORT - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 07/11/2024)
07/11/24	Vanda Pharmaceuticals Inc v. Inventia Healthcare Ltd 1:15-CV-00362 ( D. DE )	[SEALED] Joint STATUS REPORT - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 07/11/2024)
07/11/24	Vanda Pharmaceuticals Inc v. Inventia Healthcare Ltd 1:15-CV-00362 ( D. DE )	[SEALED] Joint STATUS REPORT - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 07/11/2024)